April 14, 2021
Intellectual Property Magazine
The U.S. Court of Appeals for the Fourth Circuit ruled in favor of Finnegan client Combe in another trademark dispute over the VAGISIL trademark. The court ruled that Dr. August Wolff’s VAGISAN mark for feminine healthcare products would cause consumer confusion with Combe’s VAGISIL mark, which has proven its strength as a leader in the feminine-care product space for several decades. Wolff argued that the district court erred in finding that ‘Vagisil’ and ‘Vagisan’ are “sufficiently similar,” but the appeals court disagreed.
Doug Rettew, Anna Naydonov, and Sydney English represented Combe in the district court case and the appeal. They said, “This marks another milestone for the client’s enforcement efforts and comes on the heels of a separate recent trial victory before the Trademark Trial and Appeal Board, where VAGISERT was refused as confusingly similar to Combe’s Vagisil and Vagistat marks.”
Read “Personal-Care Company Combe Victorious in Trademark Appeal”
Press Release
October 6, 2026
Press Release
Finnegan Wins 2026 Excellence in Construction Award for Washington, DC Office Renovation
September 25, 2026
Commentary
Federal Circuit Revives Whistleblower Complaint Over VA's AI Claims-Processing Tool
September 25, 2026
Award/Ranking
Finnegan Named an IP Litigation Powerhouse in BTI Litigation Outlook 2027
September 24, 2026
Award/Ranking
Finnegan Receives Top Tier Rankings in World Trademark Review’s Inaugural Copyright 1000 2026
September 23, 2026
Press Release
Finnegan Secures Precedential Pro Bono Federal Circuit Victory for AI Whistleblower
September 23, 2026
Commentary
New Thomas Pink Womenswear Lines Strain ‘Pink’ Pact with Victoria’s Secret
September 21, 2026
Commentary
FORUM IP Talks: Dr. Jochen Herr on UPC, FRAND, and Cross-Border Enforcement Topics
September 20, 2026
Due to international data regulations, we’ve updated our privacy policy. Click here to read our privacy policy in full.